-+ 0.00%
-+ 0.00%
-+ 0.00%

Barclays Initiates Coverage On ANI Pharmaceuticals with Overweight Rating, Announces Price Target of $100

Benzinga·12/09/2025 15:27:43
语音播报
Barclays analyst Glen Santangelo initiates coverage on ANI Pharmaceuticals (NASDAQ:ANIP) with a Overweight rating and announces Price Target of $100.